China's Stricter PM2.5 Standard Could Avert 233,000 Premature Deaths Annually

A new health impact assessment shows that China's revised 25 µg m⁻³ annual PM2.5 limit could avert over 233,000 premature deaths in 2024 and achieve 83% of the progress needed for the WHO's 2040 halving target, with benefits varying widely by disease.

DC Metrowire Staff
••Environment & Sustainability
China's Stricter PM2.5 Standard Could Avert 233,000 Premature Deaths Annually

A health impact assessment published in Environmental Science and Ecotechnology finds that China's tightened annual fine particulate matter (PM2.5) standard of 25 micrograms per cubic meter (µg m⁻³) could substantially reduce premature deaths and move the country closer to the World Health Organization's 2040 goal of halving air-pollution-related mortality. The study, led by researchers at Peking University Health Science Center and the Chinese Academy of Environmental Planning, estimates that full compliance with the 25 µg m⁻³ limit in 2024 would have averted approximately 233,668 premature deaths (95% uncertainty interval: 198,354–270,734), a 16.1% reduction from observed levels. This is about 4.3 times the 53,985 deaths that would have been avoided under the former 35 µg m⁻³ standard.

China introduced a 35 µg m⁻³ annual PM2.5 limit in 2012 and cut population-weighted exposure from 62.8 to 29.7 µg m⁻³ between 2013 and 2024. In 2026, the country revised its National Ambient Air Quality Standards to 25 µg m⁻³, with an interim 30 µg m⁻³ phase from 2026 to 2030. The study quantifies the health returns of these stricter limits by integrating high-resolution PM2.5 data, gridded population estimates, and disease-specific exposure–response functions for seven outcomes in the Global Burden of Disease 2023 risk set.

The findings reveal that health gains are strongly disease-specific. Under the 25 µg m⁻³ scenario, mortality fell by 22.8% for chronic obstructive pulmonary disease (COPD), 18.4% for stroke, 18.4% for lung cancer, 18.0% for lower respiratory infections, and 16.0% for ischemic heart disease. In contrast, reductions were only 1.4% for dementia and 1.1% for type 2 diabetes mellitus, with the dementia estimate requiring caution due to weaker evidence. Nationally, the PM2.5-attributable fraction of mortality declined from 32.5% in 2015 to 22.6% in 2024.

Full compliance with the 35, 30, and 25 µg m⁻³ standards would increase PM2.5-specific progress toward the WHO halving target to 66.2%, 72.6%, and 83.4%, respectively. COPD would exceed the 50% halving benchmark under the 25 µg m⁻³ scenario, whereas dementia and type 2 diabetes would remain far behind. A sensitivity analysis using the Global Exposure Mortality Model confirmed the pattern, with 3.9 times more deaths averted under 25 than 35 µg m⁻³.

The study's implications extend beyond China. Because abatement costs are rising and population aging can offset exposure-related gains, the authors argue that future standards should be evaluated by disease-specific health returns, not compliance rates alone. Policymakers could prioritize regions with large populations and high PM2.5 exposure, where compliance with 25 µg m⁻³ would yield the largest gains, and pair air-quality control with older-adult protection, clinical prevention, and chronic-disease management. The framework, detailed in the study published with DOI 10.1016/j.ese.2026.100781, could inform other developing countries seeking to tighten PM2.5 limits while tracking progress toward the WHO 2040 halving target.

Blockchain Registration

QR Code for Blockchain Registration